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SUMMARY
The N-formyl-methionyl peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, when
tested at differing concentrations, proportionally increased both in vitro cell locomotion and the
expression of surface receptors for C3b on human peripheral blood neutrophils and monocytes.
In contrast, the unformylated peptides, Met-Leu-Phe and Me--Met-Phe, had no chemotactic
or complement receptor-enhancing activity at comparable concentrations. Casein and supernatants
from human lymphocytes (cultured either in the presence or absence of phytohaemagglutinin),
also recognized as chemotactic agents for human neutrophils and monocytes, enhanced C3b
receptors on these cells in a similar dose-dependent fashion. These data, taken together with
our previous findings with the eosinophil, suggest that in addition to promoting cell locomotion a
further biological function of leucoattractants may be their capacity to render complement
receptors more freely available thereby increasing the magnitude of adhesion of phagocytic cells
to opsonized particles.
INTRODUCTION
We recently reported that eosinophil chemotactic factors (including the ECF-A tetrapeptides (Val-
Gly-Ser-Glu and Ala-Gly-Ser-Glu), histamine and imidazoleacetic acid) markedly enhanced the
expression of receptors for complement (C3b and C4) on human eosinophils (Anwar & Kay, 1977 and
1978). Therefore, it seemed important to determine whether other phagocytic cells, such as human
neutrophils and monocytes, undergo similar complement receptor enhancement following incubation
with substances known to promote their migration in vitro. If, in addition to promoting cell locomotion,
leucoattractants also render complement receptors more freely available this would provide a mechanism
whereby the degree of adhesion of phagocytic cells to opsonized particles was increased. The studies
reported here employed synthetic bacterial-associated N-formyl-methionyl peptides, as their chemical
structure is clearly defined and potent chemotactic activity well documented (Schiffman, Corcoran &
Wahl, 1975; Showell et al, 1976). In addition, we examined other recognized human neutrophil and
monocyte leucoattractants for complement receptor enhancement. These included supernatants from
cultured lymphocytes (Ward, Remold & David, 1969; Snyderman et al., 1972) and casein (Keller &
Sorkin, 1967).
MATERIALS AND METHODS
F-Met-Leu-Phe was a gift from Dr Dereck Hudson (Royal Postgraduate Medical School, London). F-Met-Met-Phe,
Met-Leu-Phe and Met-Met-Phe were gifts from Miles Laboratories (Stoke Poges). F-Met-Phe was obtained from Sigma
Chemical Company (St Louis, Missouri, U.S.A.). Other materials were obtained as follows. Preservative-free heparin (Evans
Medical, Liverpool); casein (BDH Chemicals Ltd, Poole); phytohaemagglutinin (PHA-P, Wellcome Reagents Ltd.,
Beckenham); dextran (Lomodex 70, Fisons Pharmaceuticals, Loughborough); Ficoll and Hypaque (Pharmacia, Uppsala,
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Sweden); ovalbumin five times crystallized (Koch Light Laboratories, Colnbrook); cellulose nitrate filters, 8 and 0 45-pm
pore size (Sartorius-Membrane Filters, Gottingen, West Germany); polycarbonate (Nucleopore) 5-pum pore size filters
(Neuroprobe, Bethesda, Maryland, U.S.A.).
Preparation ofEACl423b (EAC). This has been described in detail elsewhere (Anwar & Kay, 1977) and was briefly as
follows. Dextrose-gelatin-Veronal buffer (DGVB2 +, pH 74) was used for washing sheep erythrocytes (E) during sensitization
and coating with various complement components and was prepared by mixing equal volumes of isotonic Veronal-buffered
saline (containing 0-0015 M Ca2 +, 0 0005 M Mg2 + and 0-1% gelatin-Veronal buffer (GVB2 +)) with 5% dextrose in water
containing the same concentration of Ca2 + and Mg2 +. The IgM fractions of rabbit antisera to sheep red cells were prepared
by Sephadex G-200 gel filtration (Shevach et al., 1972). Functionally pure human complement components were added
sequentially to EAM'ab to prepare C3b-coated cells. The amounts were as follows: 400 effective molecules of C1, 400 of C4,
50 of C2 and 500 (for neutrophils) or 400 (for monocytes) of C3. This amount of C4 was insufficient to give EAC14 rosettes
with neutrophils, eosinophils or monocytes (Anwar & Kay, 1977).
In some experiments fresh human AB serum diluted with DGVB2 + was used as a source of complement. Equal volumes
of EAMrab at a concentration of 1 x 108 cells/ml and human AB serum were mixed and incubated for 30 min at 37C,
washed twice in DGVB2 + and resuspended in the same buffer to a concentration of 1 x 108 red blood cells/ml. The dilution
of fresh serum was adjusted to give between 20 and 30% of neutrophil or monocyte rosettes and was usually between 1 in 600
and 1 in 1000.
Neutrophils and monocytes. Blood from healthy volunteers was drawn into plastic tubes containing 10 units of preservative-
free heparin/ml. The red cells were sedimented with 70% dextran; 1 part dextran to 4 parts blood v/v for 60 min at room
temperature. The leucocyte-rich plasma was then layered over Ficoll-Hypaque (specific gravity 1-078) at 4°C in 15 ml
plastic conical centrifuge tubes and centrifuged at 4°C for 40 min at 400 g. The pellet, containing red blood cells and gran-
ulocytes, was resuspended in 0-82% ammonium chloride as described (Boyle, 1968), to lyse the red cells. Monocytes,
usually from the same donors, were separated on Ficoll-Hypaque gradients according to the method of Boyum (1968). The
separated cells were finally washed twice in medium 199, pH 7.4, and the cell count adjusted to 2 x 106 cells/ml for neutro-
phils or 1 x 106 monocytes/ml.
Lymphocyte supernatants. 'Stimulated lymphocyte supernatants' were prepared from suspensions of human peripheral
blood mononuclear cells, separated on a discontinuous gradient of Ficoll-Hypaque as described above, and contained 3 x 106
leucocytes/ml in medium 199. Under sterile conditions, and with added penicillin and streptomycin, 9 P1 of PHA-P (0.5
pg/ml) were added to 3 ml of the mononuclear cell suspension. The cells were incubated for 3 days at 37°C in a humidified
atmosphere containing 5% CO2. After incubation the supernatants were harvested by centrifugation, divided into portions
and stored at - 70°C until use. The 'unstimulated lymphocytes' were prepared in an identical fashion with the exception that
PHA-P was added at the termination of the 3 day incubation period.
EAC rosettes. Equal volumes of neutrophils (2 x 106/ml) or monocytes (1 x 106/ml) and various concentrations of the
leucoattractants under study, or medium alone as control, were mixed and incubated in a shaking water bath at 37°C for 30
min. The cells were then washed twice in medium 199 and the numbers re-adjusted to their original concentration in the
same medium. A portion (0 1 ml) of EAC (1 x 108/ml) was added to 0 1 nml of the leucocyte suspension, the mixtures centri-
fuged at 100 g for 10 min at 4°C, and the pellets incubated at 37°C for 30 min. The pellet was gently resuspended and smears
prepared on clean glass slides in duplicate. These were dried quickly in air, fixed in 95% methanol and stained with May
Grunwald/Giemsa. Leucocytes with three or more adherent sheep red cells were termed rosettes. In each slide 200 neutro-
phils or monocytes were counted and the increase in the percentage of rosetting cells following incubation with the various
leucoattractants was calculated.
Cell locomotion. The capacity of neutrophils or mononuclear cells to migrate towards a concentration gradient of various
leucoattractants has been described in detail elsewhere (Kay, Pepper & McKenzie, 1974; Campbell, 1977). For neutrophils
(Boyum, 1968), cellulose nitrate filters of 8pum pore size were employed using an incubation time of 90 min at 37°C. The cell
count was adjusted to 2 x 106/ml in medium 199 containing 0.5% ovalbumin at pH 7-4. Only those cells which had migrated
across the entire thickness of the micropore were counted. Cells were counted under a high power (x 40) objective and the
average number in five fields was recorded (mean cell count). Monocyte chemotaxis was measured using the double filter
technique (Campbell, 1977) with the exception that the 'Boyden chamber' supplied by Neuroprobe, Inc., Bethesda, Mary-
land, was used instead of the Sykes-Moore type of chamber. In all experiments with neutrophils or monocytes the values
obtained from the controls (medium 199 alone) were subtracted from the values obtained with the various agents being
tested.
RESULTS
The percentage increases in C3b rosettes and the numbers of neutrophils migrating through the micro-
pore filters were directly related to the concentrations of the formyl-methionyl peptides (Fig. 1). The
magnitude of these two biological events appeared to increase proportionally with increasing concentra-
tions of the peptides. With F-Met-Leu-Phe appreciable activity was observed from 10-8 to 101-0 mol/
1, but not at 10-11 mol/l. With F-Met-Met-Phe neutrophil chemotaxis and complement receptor
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FIG. 1. The association between the percentage increase in neutrophil C3b rosettes and neutrophil locomotion
by formylated and unformylated methionyl peptides. The symbols represent the concentration of the peptides
in mol/1 and are as follows: 10+5 (0), 10-6 (0), 10- (A), 10-8 (A), 10-9 (A), 10-10 (LI) and 101- (v).
The results are the mean values of three experiments (five experiments with F-Met-Leu-Phe). Receptor
enhancement and chemotaxis were performed on cells from the same volunteers (with the exception of two
experiments with F-Met-Leu-Phe).
FIG. 2. The association between the percentage increase in monocyte C3b rosettes and monocyte locomotion
by formylated and unformylated methionyl peptides. The symbols represent the concentrations of the peptides
in mol/l and are as follows: 10-5 (e), 10-6 (0), 10-' (A), 10-8 (A) and 10-9 (U). The results are the mean
values of three experiments. Receptor enhancement and chemotaxis were performed on cells from the same
volunteers.
TABLE 1. Human neutrophil and monocyte complement receptor enhancement by
lymphocyte supernatants and casein. N = neutrophils, M = monocytes. The
results are the mean+ s.e. of three experiments. The lymphocyte supernatants and
casein were tested for neutrophil and monocyte chemotactic activity and gave
results comparable to that described in our previous study (Kay & McVie, 1977)
C3b Rosettes (% increase)
Dilution
1:4 1:8 1:16 1:32
Lymphocyte supernatant N 64+4 49+ 4 34+ 2 16+ 8
(PHA-stimulated) M 84+5 52+7 - 2+3
Lymphocyte supernatant N 69+ 3 33+ 5 25+ 5 1+ 5
(unstimulated) M - 39+ 7 11+ 7 -2+ 3
Concentration (mg/ml)
30 2-0 1-5 10
Casein N 60+ 11 64+ 6 34+ 3 23+ 5
M 97+ 12 76+ 17 - 39+ 4
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enhancement were observed at 10'- aud 10-8 mol/l and with F-Met-Phe at 10-' and 10-6. The un-
formylated peptides, Met-Leu-Phe and Met-Met-Phe, gave virtually no responses either with neutro-
phil C3b-receptor enhancement or chemotaxis.
Similar results were obtained with human blood monocytes (Fig. 2) although the concentrations of
the formyl-methionyl peptides required to demonstrate chemotaxis and complement receptor enhance-
ment were higher than those required for the neutrophil. With F-Met-Leu-Phe activity was observed at
i0-' and 10'8 mol/l with little enhancement and cell locomotion at 10-' mol/l. With F-Met-Met-Phe
and F-Met-Phe a clear effect on cell locomotion and rosette expression was demonstrable at 10-' and
10-6 mol/l, but not at 10'- mol/l. The unformylated peptides, Met-Leu-Phe and Met-Met-Phe, gave
very low values in monocyte complement receptor enhancement and monocyte chemotaxis.
Casein, previously shown to be a potent chemoattractant for neutrophils and monocytes (Keller &
Sorkin, 1967), also enhanced C3b receptors on these cell types (Table 1). Similar results were obtained
with cultured lymphocyte supernatants. A greater amount of neutrophil and monocyte chemotactic
activity was found in cultures prepared in the presence ofPHA, although the 'unstimulated' lymphocyte
supernatants also promoted the migration of human leucocytes, as was previously shown (Snyderman
et al., 1972). Similarly, complement receptor enhancement was greater with 'stimulated' as compared to
'unstimulated' supernatants for both neutrophils and monocytes (Table 1).
The time-course of complement receptor enhancement on neutrophils and monocytes was similar,
maximal effect being observed between 30 and 60 min. Irrespective ofwhether the indicator red cells were
EAM with whole serum as a source of complement, or EAM and purified Cl, C4, C2 and C3, the per-
centage increase in rosettes either as a function of time or the concentration of chemoattractant, was
virtually identical for both neutrophils and monocytes.
DISCUSSION
Inthis reportwe haveshown that formyl-methionylpeptides, in addition to promotingcell migration in vitro,
also increased the expression of C3b receptors on neutrophils (Fig. 1) and monocytes (Fig. 2). We have
therefore, confirmed previous reports on the leucoattractant properties of these compounds (Schiffman
et al., 1975; Showell et al., 1976) and shown that in addition they have a previously undescribed biological
activity-complement receptor enhancement. Both activities, i.e. leucoattraction and complement
receptor enhancement, occurred in parallel since increasing concentrations of the peptides promoted
concomitant increases in both the degree of receptor enhancement and the numbers of neutrophils or
monocytes migrating through the micropore filters. In contrast, the unformylated peptides, Met-Leu-
Phe and Met-Met-Phe, were inactive in both biological systems suggesting that the specificity for
formylation applies to both complement receptor enhancement and locomotion.
Enhancement of complement receptors by 'chemotactic factors' was first described using human
eosinophils (Anwar & Kay, 1977, 1978). In these reports we showed that receptors for C3b and C4
(but not C3d or IgG (Fc)) were 'enhanced' in the sense that previously recognized eosinophilotactic
agents such as the ECF-A tetrapeptides, histamine or imidazoleacetic acid produced an increase in the
percentage of eosinophils forming rosettes with the appropriate indicator red cells. As described else-
where (Anwar & Kay, 1978) possible explanations of the mechanisms of complement receptor enhance-
ment include 'membrane unfolding', 'receptor externalization' and 'subunit association'. The generation
of 'new' receptors during the incubation with chemotactic factors was considered unlikely since optimal
enhancement of eosinophil complement receptors was found to be between 30 and 60 min. A similar
time course for complement receptor enhancement on neutrophils and monocytes has also been observed
with neutrophils and monocytes (Glass, E.J., Salter, D.McG. & Kay, A. B., unpublished observations).
The term 'leucoattraction' and 'cell locomotion' has been used only in the sense that the various agents
which we tested produced migration of neutrophils and monocytes towards a gradient across a micropore
Elter. Although we have drawn the general conclusion that agents which promote cell locomotion also
nhance complement receptors on the leucocytes they chemoattract, we cannot say whether this effect is
-elated to their chemotactic and/or chemokinetic principles. Showell et al. (1976), using the 'chequer-
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board' titration method previously described (Zigmond & Hirsch, 1973) to distinguish true chemotaxis
from chemokinesis, were able to show that F-methionyl peptides caused directional migration as well as
increasing the rate of cell movement. In order to establish whether the chemotactic and/or chemo-
kinetic property is necessary for complement receptor enhancement on human leucocytes further
studies will be required using substances which increase random migration, but are not chemotactic and
vice versa. For instance, Wilkinson et al. (1977) reported that mouse lymph node lymphocytes responded
in chemokinesis, but not chemotaxis, to human and bovine serum albumins.
The relative activities of the formylated peptides used in this study were, for neutrophils, F-Met-
Leu-Phe > F-Met-Met-Phe > F-Met-Phe. Similar results, in terms of relative potencies were observed
in the study by Showell et al. (1975) in which chemotaxis and lysosomal enzyme release from rabbit
neutrophils were tested. With monocytes about one hundred-fold more F-Met-Leu-Phe, F-Met-Met-
Phe or F-Met-Phe was required to give comparable biological effects to that of the neutrophil (Figs 1 and
2). Furthermore in the human monocyte studies (Fig. 2), F-Met-Phe had a similar potency to F-Met-Met
Phe in both cell locomotion and rosette enhancement. This is in contrast to the report of Showell et al.
(1976) in which F-Met-Met-Phe was found to be 1900 times more active than F-Met-Phe in promoting
chemotaxis of rabbit neutrophils.
We have not yet had the opportunity to examine fully the effects of chemotactic agents on cell surface
markers other than those for complement. However, in a previous report we showed that eosinophilo-
tactic agents had no apparent effect on IgG (Fc) receptors (Anwar & Kay, 1977 and 1978) and recent
preliminary data indicate that on neutrophils and monocytes these receptors are also unaffected by
leucoattractants (Salter, D.McG. & Glass, E.J., unpublished observations). Also, we have yet to ascer-
tain whether, like eosinophils, complement receptor enhancement on neutrophils and monocytes
applies only to C3b and C4 and not C3d.
It is tempting to speculate that complement receptor enhancement may be an important biological
phenomenon in terms of the events which surround (i) the directional migration of cells into sites of
inflammation and (ii) the subsequent adhesion of leucocytes to particles opsonized by complement, i.e.
that leucocytes are primed for the adhesion process prior to their actual attachment. The N-formyl-
methionyl peptides and the other leucoattractants tested (Table 1) enhanced C3b receptors on those cells
in which they induced locomotion. Therefore, the present work, taken together with our previous
findings with the eosinophil (Anwar & Kay, 1977 and 1978), supports the general hypothesis that leuco-
attractants enhance complement receptors on human phagocytic cells.
This work was supported by the Medical Research Council and the Cancer Research Campaign.
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